Kom i gang med din enkle Migrene
Hvorfor smart påfylling?
Gå aldri tom for systemet ditt
Vær konsekvent med rutinene dine
Fleksibelt abonnement. Kanseller når som helst.
Eksklusive bonuser kun for medlemmer
Prioritert tilgang til fremtidige lanseringer
Access to subscriber-only benefits
Alt du trenger ingenting improvisert
Dette er ikke et enkelt produkt. Det er et koordinert system som er utformet for å fungere sammen – ikke isolert.
Presisjonsendringer konsistens.
Fordi levering er viktig – ikke bare komponenter.
Hvordan systemet fungerer i det virkelige liv
Det er her de fleste tilnærmingene mislykkes.
Ikke eskalering. Strukturert beredskap.
Structured Formulation Not Random Ingredients
Each medicinal plant has a reason for being here — selected for its history of use, scientific interest, and defined role within the complete SinaVita® formulation.
Echium Amoenum
Echium amoenum has been used for centuries in traditional Persian medicine and has since attracted scientific interest for its neuroactive properties. Modern research has investigated the plant in areas including anxiety, mood and pain, while identifying naturally occurring compounds such as rosmarinic acid, flavonoids and anthocyanins.
- Centuries of traditional medicinal use
- Investigated in human clinical research
- Studied in areas including anxiety, mood and pain
- Selected as part of the coordinated SinaVita® formulation
Matricaria Chamomilla
Matricaria chamomilla has a long history as a medicinal plant and has also been investigated directly in human migraine research. A randomized, double-blind, placebo-controlled clinical study evaluated a standardized chamomile preparation in people with migraine without aura, while broader research has identified naturally occurring compounds including apigenin, chamazulene and α-bisabolol.
- Long history of traditional medicinal use
- Investigated directly in human migraine research
- Studied in a randomized, double-blind, placebo-controlled trial
- Selected as part of the coordinated SinaVita® formulation
Eucalyptus Globulus
Eucalyptus globulus has a long history of medicinal use and is formally recognized in a European Union herbal monograph. Eucalyptus preparations have traditionally been used through inhalation, while eucalyptus oil has been evaluated by the European Medicines Agency in therapeutic areas including pain and inflammation and cough and cold. Its established history of inhalation use makes it a purposeful component within the broader SinaVita® formulation.
- Long history of traditional medicinal use
- Recognized in a European Union herbal monograph
- Traditionally used through inhalation
- Selected for its role within the coordinated SinaVita® formulation
Nigella Sativa
Nigella sativa has a long history as a medicinal plant and has become the subject of extensive modern research. Its naturally occurring constituent thymoquinone has received particular scientific attention, while randomized clinical trials and meta-analyses have investigated Nigella sativa in relation to inflammatory and oxidative-stress biomarkers. This research profile makes it a purposeful component within the broader SinaVita® formulation.
- Long history of traditional medicinal use
- Contains the widely studied constituent thymoquinone
- Investigated across randomized human clinical trials
- Studied in relation to inflammation and oxidative-stress biomarkers
Tanacetum Parthenium
Tanacetum parthenium, commonly known as feverfew, has a long history as a medicinal plant associated with migraine and headache. Unlike many traditionally used plants, feverfew has also been investigated specifically for migraine across multiple randomized, double-blind, placebo-controlled clinical trials. A recent systematic review and meta-analysis evaluated nine such trials involving 899 participants, reinforcing its continued scientific relevance in migraine research.
- Long history of traditional use associated with migraine
- Investigated specifically in human migraine research
- Evaluated across randomized, double-blind, placebo-controlled trials
- Recent meta-analysis included 9 trials and 899 participants
Lavandula Officinalis
Lavandula officinalis has a long history as a medicinal plant, while modern research has extended its investigation directly into migraine. In a placebo-controlled human clinical trial, lavender essential oil was studied through inhalation during migraine attacks, with researchers evaluating headache severity and associated symptoms. Its combination of traditional medicinal use, direct migraine research and inhalation-based investigation makes lavender particularly relevant within the broader SinaVita® formulation.
- Long history of traditional medicinal use
- Investigated directly in people with migraine
- Studied through inhalation in a placebo-controlled clinical trial
- Clinical research evaluated migraine headache severity and associated symptoms
Ofte stilte
Spørsmål
Q1. Er SinaVita® en medisinsk behandling?
Ans: Nei. SinaVita® Migrenestøtte er et ikke-farmakologisk strukturert støttesystem. Det er utviklet for å utfylle, ikke erstatte, profesjonell medisinsk rådgivning.
Q2. Kan SinaVita® erstatte medisinen min?
Ans: Nei. SinaVita® er ikke en erstatning for medisiner. Rådfør deg alltid med legen din før du endrer en behandlingsplan.
Q3. Er forstøverenheten inkludert?
Ans: Ja, nettforstøveren er inkludert i den komplette systempakken som en komponent for presisjonslevering.
Q4. Trenger jeg å abonnere?
Ans: Nei. Du kan kjøpe systemet som en engangsbestilling. Smart Refill-abonnementet er valgfritt og kan kanselleres når som helst.
Q5. Er dette trygt for personer med sensitivitet?
Ans: SinaVita®-produkter er utviklet under ISO-sertifisert kvalitetsstyring. Sjekk imidlertid alltid ingredienslisten og kontakt helsepersonell hvis du har spesifikke sensitiviteter eller allergier.
Q6. What if SinaVita® isn’t right for me?
Ans: We want you to feel confident trying the complete SinaVita® system. Your purchase is backed by our 30-day money-back guarantee, giving you time to experience the system and decide whether it fits your routine.
Q7. How quickly should I expect results?
Ans: SinaVita® is designed around consistent use rather than a one-time approach. Earlier clinical research on the formulation followed migraine outcomes over several months, including assessments through four months. Individual experiences can vary, so we recommend following the system consistently according to the directions for use.
Q8. What if I need additional support during a migraine period?
Ans: The system is designed with flexibility in mind. Alongside the daily routine, selected components can provide additional support when early migraine signals appear or around postdrome, according to the directions for use.
Q9. What if I already use migraine medication?
Ans: SinaVita® is designed as a complementary support system, not as a replacement for prescribed medication or professional medical care. If you use medication or have questions about combining products, speak with your healthcare professional.
Q10. What research and safety evaluation support SinaVita®?
Ans: SinaVita® builds on a long-standing research and development program that includes clinical migraine research, preclinical safety evaluation and ingredient-specific scientific evidence. Earlier research on the formulation was reported at the 60th Annual Scientific Meeting of the American Headache Society, with clinical development data involving more than 500 migraine patients. Preclinical safety evaluation also included acute and repeated-exposure toxicological assessment with histological examination of major organs. Today, this research foundation continues through further scientific development of the SinaVita® system.
Q11. What quality standards are behind SinaVita®?
Ans: SinaVita® is developed within internationally recognized quality-management systems, including ISO 13485:2016 for medical devices, ISO 9001:2015 for quality management and ISO 22000:2018 for food safety management. The SinaVita® Migraine Support Tablets are dietary supplements, while the Nasal Spray and Inhalation Drops are medical devices developed in accordance with MDR (EU) 2017/745 and carry CE marking. Regulatory and technical documentation is maintained according to the applicable requirements for each product category.
